| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $124.8M | +103.6% |
| R&D Expense | $501.7M | -4.5% |
| SG&A Expense | $687.4M | +14.5% |
| Operating Income | $4.24B | +460.9% |
| Interest Expense | $34.8M | +24.3% |
| Pre-tax Income | $4.25B | +447.3% |
| Income Tax | $22.2M | +328.2% |
| Net Income | $4.35B | +531.0% |
| EPS (Basic) | $5.55 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.54B | +289.8% |
| Accounts Receivable | $53.5M | +76.3% |
| Inventory | $35.3M | +1176.7% |
| Current Assets | $6.73B | +274.3% |
| Total Assets | $7.22B | +202.2% |
| Current Liabilities | $266.8M | -2.1% |
| Long-term Debt | $430.6M | +14.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$765.3M | +9.3% |
| Capital Expenditures | $1.4M | -89.1% |
| Investing Cash Flow | $5.20B | — |
| Financing Cash Flow | $419.4M | -16.0% |
| Free Cash Flow | -$766.6M | +10.4% |
| +490.8% |
| EPS (Diluted) | $5.23 | +468.3% |
| Total Liabilities |
| $774.0M |
| -1.0% |
| Stockholders' Equity | $5.97B | +415.5% |